Učitavanje...
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected nearly 118 million people and caused ~2.6 million deaths worldwide by early 2021, during the coronavirus disease 2019 (COVID-19) pandemic. Although the majority of infected patients show mild-to-moderate symptoms, a small frac...
Spremljeno u:
| Izdano u: | NPJ Regen Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8245638/ https://ncbi.nlm.nih.gov/pubmed/34193864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41536-021-00147-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|